{"id":46253,"date":"2025-11-10T23:19:25","date_gmt":"2025-11-10T15:19:25","guid":{"rendered":"https:\/\/flcube.com\/?p=46253"},"modified":"2025-11-10T23:19:27","modified_gmt":"2025-11-10T15:19:27","slug":"insilico-medicine-eli-lilly-forge-strategic-ai%e2%80%91driven-drug-discovery-alliance","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46253","title":{"rendered":"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance"},"content":{"rendered":"\n<p><strong>Insilico Medicine<\/strong>, a leader in artificial\u2011intelligence\u2011powered drug discovery, today announced a strategic collaboration with <strong>Eli\u202fLilly\u202f(<a href=\"https:\/\/www.google.com\/finance\/quote\/LLY:NYSE\">NYSE: LLY<\/a>)<\/strong> to accelerate the discovery and development of innovative therapies. Leveraging the company\u2019s proprietary <strong>Pharma.AI<\/strong> platform, the partnership will combine Insilico\u2019s advanced computational capabilities with Eli\u202fLilly\u2019s deep expertise in drug development and disease science.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-scope-of-the-collaboration\">Scope of the Collaboration<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Technology Engine<\/strong> \u2013 Insilico will use its validated Pharma.AI platform to generate, design, and optimize candidate molecules for targets identified jointly by the two parties.<\/li>\n\n\n\n<li><strong>Development Pathway<\/strong> \u2013 Eli\u202fLilly will oversee all downstream activities, from IND\u2011enabling studies to clinical development and commercialization.<\/li>\n\n\n\n<li><strong>Financial Terms<\/strong> \u2013 Insilico is entitled to potential earnings of <strong>over USD\u202f100\u202fmillion<\/strong>, encompassing upfront payments, milestone fees, and tiered net\u2011sales royalties for any resulting drugs.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strategic-context\">Strategic Context<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Historical Foundations<\/strong> \u2013 The alliance builds on a 2023 software\u2011licensing partnership between Insilico and Lilly that introduced the AI platform into Lilly\u2019s R&amp;D workflow.<\/li>\n\n\n\n<li><strong>Industry Significance<\/strong> \u2013 The collaboration underscores the accelerating shift toward AI\u2011enabled drug discovery and the opportunity to expedite therapeutic breakthroughs across diverse disease indications.<\/li>\n\n\n\n<li><strong>Future Outlook<\/strong> \u2013 Combined expertise is expected to reduce lead\u2011optimization timelines, lower development costs, and enhance the probability of clinical success.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>Statement herein are forward\u2011looking and involve risks and uncertainties. Actual results may differ materially from those expressed.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Insilico Medicine, a leader in artificial\u2011intelligence\u2011powered drug discovery, today announced a strategic collaboration with Eli\u202fLilly\u202f(NYSE:&#8230;<\/p>\n","protected":false},"author":1,"featured_media":46256,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[99,164,911],"class_list":["post-46253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ai","tag-insilico-medicine","tag-nyse-lly"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Insilico Medicine, a leader in artificial\u2011intelligence\u2011powered drug discovery, today announced a strategic collaboration with Eli\u202fLilly\u202f(NYSE: LLY) to accelerate the discovery and development of innovative therapies. Leveraging the company\u2019s proprietary Pharma.AI platform, the partnership will combine Insilico\u2019s advanced computational capabilities with Eli\u202fLilly\u2019s deep expertise in drug development and disease science.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46253\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance\" \/>\n<meta property=\"og:description\" content=\"Insilico Medicine, a leader in artificial\u2011intelligence\u2011powered drug discovery, today announced a strategic collaboration with Eli\u202fLilly\u202f(NYSE: LLY) to accelerate the discovery and development of innovative therapies. Leveraging the company\u2019s proprietary Pharma.AI platform, the partnership will combine Insilico\u2019s advanced computational capabilities with Eli\u202fLilly\u2019s deep expertise in drug development and disease science.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46253\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-10T15:19:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-10T15:19:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1008.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance\",\"datePublished\":\"2025-11-10T15:19:25+00:00\",\"dateModified\":\"2025-11-10T15:19:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253\"},\"wordCount\":241,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1008.webp\",\"keywords\":[\"AI\",\"Insilico Medicine\",\"NYSE: LLY\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46253#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46253\",\"name\":\"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1008.webp\",\"datePublished\":\"2025-11-10T15:19:25+00:00\",\"dateModified\":\"2025-11-10T15:19:27+00:00\",\"description\":\"Insilico Medicine, a leader in artificial\u2011intelligence\u2011powered drug discovery, today announced a strategic collaboration with Eli\u202fLilly\u202f(NYSE: LLY) to accelerate the discovery and development of innovative therapies. Leveraging the company\u2019s proprietary Pharma.AI platform, the partnership will combine Insilico\u2019s advanced computational capabilities with Eli\u202fLilly\u2019s deep expertise in drug development and disease science.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46253\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1008.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1008.webp\",\"width\":1080,\"height\":608,\"caption\":\"Insilico Medicine & Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46253#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance - Insight, China&#039;s Pharmaceutical Industry","description":"Insilico Medicine, a leader in artificial\u2011intelligence\u2011powered drug discovery, today announced a strategic collaboration with Eli\u202fLilly\u202f(NYSE: LLY) to accelerate the discovery and development of innovative therapies. Leveraging the company\u2019s proprietary Pharma.AI platform, the partnership will combine Insilico\u2019s advanced computational capabilities with Eli\u202fLilly\u2019s deep expertise in drug development and disease science.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46253","og_locale":"en_US","og_type":"article","og_title":"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance","og_description":"Insilico Medicine, a leader in artificial\u2011intelligence\u2011powered drug discovery, today announced a strategic collaboration with Eli\u202fLilly\u202f(NYSE: LLY) to accelerate the discovery and development of innovative therapies. Leveraging the company\u2019s proprietary Pharma.AI platform, the partnership will combine Insilico\u2019s advanced computational capabilities with Eli\u202fLilly\u2019s deep expertise in drug development and disease science.","og_url":"https:\/\/flcube.com\/?p=46253","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-10T15:19:25+00:00","article_modified_time":"2025-11-10T15:19:27+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1008.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46253#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46253"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance","datePublished":"2025-11-10T15:19:25+00:00","dateModified":"2025-11-10T15:19:27+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46253"},"wordCount":241,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46253#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1008.webp","keywords":["AI","Insilico Medicine","NYSE: LLY"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46253#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46253","url":"https:\/\/flcube.com\/?p=46253","name":"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46253#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46253#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1008.webp","datePublished":"2025-11-10T15:19:25+00:00","dateModified":"2025-11-10T15:19:27+00:00","description":"Insilico Medicine, a leader in artificial\u2011intelligence\u2011powered drug discovery, today announced a strategic collaboration with Eli\u202fLilly\u202f(NYSE: LLY) to accelerate the discovery and development of innovative therapies. Leveraging the company\u2019s proprietary Pharma.AI platform, the partnership will combine Insilico\u2019s advanced computational capabilities with Eli\u202fLilly\u2019s deep expertise in drug development and disease science.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46253#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46253"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46253#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1008.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1008.webp","width":1080,"height":608,"caption":"Insilico Medicine & Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46253#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Insilico Medicine &amp; Eli\u202fLilly Forge Strategic AI\u2011Driven Drug Discovery Alliance"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1008.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46253"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46253\/revisions"}],"predecessor-version":[{"id":46257,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46253\/revisions\/46257"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/46256"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}